Browse > Article

Rhei Rhizoma and Chunghyuldan Inhibit Pancreatic Lipase  

Yang, Hyung-Kil (College of Oriental Medicine, Kyung Hee University)
Kim, Young-Suk (College of Oriental Medicine, Kyung Hee University)
Bae, Hyung-Sup (College of Oriental Medicine, Kyung Hee University)
Cho, Ki-Ho (College of Oriental Medicine, Kyung Hee University)
Shin, Ji-Eun (College of Pharmacy, Kyung Hee University)
Kim, Nam-Jae (East-West Medical Research Institute, Kyung Hee University)
Kim, Dong-Hyun (College of Pharmacy and East-West Medical Research Institute, Kyung Hee University)
Publication Information
Natural Product Sciences / v.9, no.1, 2003 , pp. 38-43 More about this Journal
Abstract
Pancreatic lipase-inhibitory activity of the rhizome of Rhei Rhizoma and its antihyperlipidemic activity were measured. Rhei Rhizoma inhibited pancreatic lipase with $IC_{50}$ value of 6.5 mg/ml (triolein as a substrate). Rhei Rhizoma significantly inhibited serum TG level in corn oil feeding-induced mice, and serum TG and cholesterol in Triton WR-1339-induced hyperlipidemic mice. However, Rhei Rhizoma did not show the hypolipidemic activity in high cholesterol diet-induced hyperlipidemic mice. When in vitro pancreatic lipase-inhibitory and in vivo antihyperlipidemic activities of Whangryunhaedoktang (WT) and Chunghyuldan (CD), which is consisted of ingredients of WT and Rhei Rhizoma, were measured, CD exhibited more potent inhibitory activities than WT. Therefore these results suggest that antihyperlipidemic activity of Rhei Rhizoma and CD may be more or less originated from the inhibition of pancreatic lipase.
Keywords
Rhei Rhizoma; Chunghyuldan; Whangryunhaedoktang; pancreatic lipase; antihyperlipidemic activity;
Citations & Related Records

Times Cited By SCOPUS : 2
연도 인용수 순위
1 Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond W., Fu P. C. Enzymatic determination of total serum cholesterol. Clin. Chem. 20, 470-5 (1974)
2 Junge, W., 'Methods of Enzymatic Analysis,' Vol. 4., ed. by Bergmeyer H. U., Verlag Chemie GmbH, Weinheim, 1984, pp. 15-25
3 Mainard, F., Madec, Y., Cholesterol, phospholipid and apo B composition of LDL; Comparison of precipitation and ultracentrifugation methods. Ann. BioI. Clin. 44, 618-623 (1986)
4 Niiho, H., Yamazaki, T., Nakajima, Y., Itoh, H., Takeshi ,T., Kinjo, J., Nohara, T Pharmacological studies on Puerariae Flos. II. The effects of Puerariae Flos on alcohol-indue d unusual metabolism and experimental liver injury in mice. Yakugaku Zasshi. 110, 604-11 (1990)
5 Olsson, A. G., Lang, P. D., Vollmar, J., Effect of bezafibrate during 4,5 years of treatment of hyperlipidemia. Atheroscleosis, 55, 195-199 (1985)   DOI   ScienceOn
6 Suenaga, T., Shirakawa, T., Harada, N., Tao, C., Yamasaki, M., Komatsu, H, Matsumoto,N., Kida, M., Kawamoto,Y., Murakami, Y., Kakamura, M., Mieno, H, Inoue, M., Kajiyama, G., Mechanism of protective effects of Ouren-Gedoku-To and San'ou-Syanshin-To on the gastric mucosa. Folia pharmacal japan. 98, 319-325 (1991)   DOI   ScienceOn
7 Yoshinaga, S., Kimura, M., Tanaka, A., Tomonaga, M., The effect of Kampa medicine 'Oren-gedoku-to' on clinical manifestations and cerebral blood flow in chronic stage of cerebrovascular diseases. J. Med. Pharm. Sco. WAKAN-YAKU, 9, 22-27 (1992)
8 Carey, M. C, Small, D. M., Bliss, C. M., Lipid digestion and absorption. Annu. Rev. Physiol., 45, 651-677 (1983)   DOI   ScienceOn
9 Kusama, H., Nishiyama, M., Ikeda, S., Pharmacological investigation of bezafibrate, a hypolipidemic agent, (I). Effect of bezafibrate on normal and experimental hyperlipidemia in rats. Folia pharmacal. Japan, 92, 175-180 (1988)   DOI   ScienceOn
10 Kim, Y. S., Jung, E. A., Chang, J. C., Yang, H. K., Kim, N. J., Cho, C. H., Bae, H. S., Lee, K. S., Kim, D. H. Effect of Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase. BioI. Pharm. Bull. 25, 1442-1445 (2002)   DOI   ScienceOn
11 Yamamoto, M., Shimura, S., Itoh, Y., Ohsaka, T., Egawa, M., Inoue, S. Antiobesity effects of lipase inhibitor CT-II an extract from edible herbs, Nomame Herba, on rats fed a high-fat diet. Int. J. Obes. Relat. Metab. Disord. 24, 758-764 (2000)   DOI   PUBMED   ScienceOn
12 Hayakawa J, Noda N, Yamada S, Mikarni E, Uno K. Studies on physical and chemical quality evaluation of crude drugs preparations. III. Analysis of Gardenia fruits and its preparations. Yakugaku Zasshi. 105, 996-1000 (1985)
13 Hong, N. D., Kim, J. W., Doo, H. K., Kim, N. J., Studies on the efficacy of combined preparation of crude drugs (V)-Effect of 'Whangryonhaedok-Tang' on the antiinflammatory, ileum of mice, blood pressure, blood glucose, total cholesterol and antibacterial activity. Kor. J. Phannacog. 13, 26-32 (1982)
14 Sardesai, V. M., Mannig, J. A., The determination of triglycerides in plasma and tissues. Clin. Chem. 14, 156-158 (1968)
15 Ballinger, A., Peikin, S. R., Orlistat: its current status as an antiobesity drug. Eur. J. Phannacol., 440, 109-117 (2002)   DOI   ScienceOn
16 Duhault, J., Boulanger, M., Beregi, L., Sicot, N., Bouvier, F. A new type of hyperlipidemic agent comparative assay in rats. Atherosclerosis. 23, 63-72 (1976)   DOI   ScienceOn
17 Raghavendra, M. P, Prakash, V.Phenylboronic acid - a potent inhibitor of lipase from Oryza stiva. J. Agric. Food Chem. 50, 6037-6041 (2002)   DOI   ScienceOn
18 The Korean Pharmacopia. 7th ed. pp. 721, 766, 778, 779, 781, 1997
19 Han, L. K., Kimura, Y., Kawashima, M., Takaku, T., Taniyama, T., Hayashi, T., Zheng, Y. N., Okuda, H. Antiobesity effects in rodents of dietary teasaponin, a lipase inhibitor. Int. J. Obes. 25, 1459-1464 (2001)   DOI   ScienceOn
20 Ohshima, Y, Takahashi, K., Hiraga, Y., Shibata, S. Studies on the evaluation of Chinese drug preparations. Determination of sennosides in the drug preparation containing Rhubarb. Shoyakugaku Zasshi. 37, 217-222 (1983)